Sun Pharmaceutical Industries Q4 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,852.2
-12.75 (-0.68%)
-12.75 (-0.68%)Volume1.16 L
Updated: Fri 13 Sep, 2024 | 15:29:45
NSE
1,853-12.40 (-0.66%)
-12.40 (-0.66%)Volume1.32 M
Updated: Fri 13 Sep, 2024 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 11,982.90 | 11,240.97 | -3.21% | 10,930.67 | 9.63% |
| Selling/ General/ Admin Expenses Total | 2,299.34 | 2,037.07 | -2.71% | 2,179.55 | 5.50% |
| Depreciation/ Amortization | 650.36 | 659.95 | 4.54% | 671.53 | -3.15% |
| Other Operating Expenses Total | 4,211.62 | 3,393.38 | 7.22% | 3,671.60 | 14.71% |
| Total Operating Expense | 9,643.37 | 8,894.07 | -0.79% | 8,944.35 | 7.82% |
| Operating Income | 2,339.53 | 2,346.90 | -12.06% | 1,986.32 | 17.78% |
| Net Income Before Taxes | 2,815.52 | 2,471.47 | -6.16% | 2,239.69 | 25.71% |
| Net Income | 2,654.58 | 2,166.01 | 5.18% | 1,984.47 | 33.77% |
| Diluted Normalized EPS | 11.50 | 9.00 | 7.01% | 8.96 | 28.38% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01PN Gadgil Jewellers IPO allotment status out. Latest GMP, steps to check allotment status online
3 min read09:42 AM IST - Markets
02Bajaj Housing Finance IPO: GMP jumps, listing date in focus after announcement of allotment status
2 min read11:31 AM IST - Markets
03Is the Indian stock market closed on Monday for Eid?
2 min read06:57 AM IST